Learn more

NIHON KOUTAI KENKYUSHO KK

Overview
  • Total Patents
    22
About

NIHON KOUTAI KENKYUSHO KK has a total of 22 patent applications. Its first patent ever was published in 1981. It filed its patents most often in Japan. Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are COMMW SERUM LAB COMMISSION, AMERICAN REGISTRY PATHOLOGY and APATH LLC.

Patent filings in countries

World map showing NIHON KOUTAI KENKYUSHO KKs patent filings in countries
# Country Total Patents
#1 Japan 22

Patent filings per year

Chart showing NIHON KOUTAI KENKYUSHO KKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Adachi Shiyouichi 20
#2 Kojima Reiko 2
#3 Asakura Akishirou 1
#4 Kogure Shiyouji 1
#5 Shirotake Kiyouko 1
#6 Mizuta Toshinobu 1
#7 Suzuki Mamoru 1
#8 Waki Seiji 1
#9 Miwa Hideyuki 1
#10 Fukamachi Isamu 1

Latest patents

Publication Filing date Title
JPS60253872A Antis-100 protein antibody
JPS60253871A Anti-apo a-1 antibody
JPS60237989A Addition agent for cell culture
JPS60214737A Preparation of saccharide chain-related antigen (tca)
JPS60119465A Method for measuring antiperoxidation power
JPS6078918A Production of thermally denaturated antigen
JPS6031057A Peroxide substance measuring method and kit thereof
JPS59227827A Chain-relating antigen originated from plasmodium, and its preparation
JPS59225119A Preparation of thermally denatured antigen
JPS59216900A Novel steroid compound and water-soluble hormone agent consisting of it
JPS59128397A Antibody for human gastric cancer
JPS5967224A Glyco-related antigen, its preparation and antiulcer agent containing the same as active constituent
JPS5913955A Method for measuring lectin juvenilization
JPS591420A Sugar chain-relating antigen and its preparation
JPS58129363A Determination of sugar side chain associated with cancer
JPS5896029A Preparation of antigen-specific b cell
JPS5859922A Cancer cell-disturbing lymphocyte
JPS5859923A Carcinostatic agent
JPS5857318A Production of lymphocytes inhibiting cancer cells
JPS5857321A Anticancer agent